Proton therapy induces biologic response to attack treatment-resistant cancers February 17, 2021 ROCHESTER, Minn. — Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist…

In the last decade, researchers have come to realize that tumors harbor bits of extrachromosomal DNA that can drive malignancy. Paul Mischel Apr 1, 2021 338 In the spring of 2012, my colleagues and I began to notice something strange in tumor…

The purpose of this study is to learn whether combining lenvatinib and pembrolizumab is a safe and effective treatment for patients with metastatic soft tissue sarcomas that cannot be surgically removed. This study will include patients with…

A team of researchers say they’ve designed a personalized cancer vaccine capable of inducing an immune response that fights off melanoma, the deadliest form of skin cancer, that lasts for several years. In a study published in the journal Nature…

It’s Spring, Passover is ending, it’s Easter Sunday….. their is a light at the end of the dark tunnel of the pandemic and hope for a new beginning. With the knowledge of new medications and technologies for early diagnosis of Chondrosarcoma, my…

On Saturday, March 20, 2021; the Chondrosarcoma CS Foundation, Inc. hosted its Second International Virtual Dialogue featuring two prominent world renown experts who introduced new techniques and innovations on how to diagnose and treat…

Two weeks from today the Chondrosarcoma Foundation will host the Second International Virtual Dialogue. It is scheduled for Saturday, March 20, 2021 from 1:00pm – 2:30pm (EST/ New York time) on Zoom. If you have not already, please register at…